SynthesisFrontiers in pharmacology2022

Licensing of Orphan Medicinal Products-Use of Real-World Data and Other External Data on Efficacy Aspects in Marketing Authorization Applications Concluded at the European Medicines Agency Between 2019 and 2021.

Frauke Naumann-Winter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.